There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

With a market cap of $124.9 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology company. The Boston, Massachusetts-based company engages in developing and commercializing ...

Good morning, Boston. Here are the five things you need to know in local business news to start your Friday, including Vertex's new drug, a new downtown hotel, Takeda's new CEO, and the ...

Moderna, Inc.; and Entrada Therapeutics, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Like other drug companies, Boston-based Vertex has a program that helps patients with insurance reduce their out-of-pocket costs for treatments. A UnitedHealth representative had no immediate comment.

Headquartered in Boston, Massachusetts, Vertex focuses on pioneering treatments for cystic fibrosis and advancing research in genetic and rare diseases, leveraging cutting-edge science to improve ...

M.D. Ph.D., 50 Northern Ave, Boston, Massachusetts 02210, Chief Scientific Officer, Executive Vice President, Global Research Vertex Pharmaceuticals Incorporated ...

There were only six biotech IPOs in Massachusetts in 2024 and just two in 2023. Meanwhile, after winning FDA approval of its Journavx treatment for acute pain, Boston’s Vertex is flying high ...

Vertex Pharmaceuticals ... Boger in 1989 and is headquartered in Boston, MA.